Immunocore Holdings plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US45258D1054

SecurityIMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
InstitutionCaption Management, LLC
Latest Disclosed Ownership661,786 shares
Latest Disclosed Value $ 19,952,848
Caption Management, LLC ownership in IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 661,786 shares of Immunocore Holdings plc - Depositary Receipt (Common Stock) (US:IMCR) valued at $19,952,848 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 94,384 shares of Immunocore Holdings plc - Depositary Receipt (Common Stock). This represents a change in shares of 601.16% during the quarter. The current value of the position is $18,960,169 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (IMCR) in the form of stock options. The firm currently holds call options representing 30,000 of underlying shares valued at $904,500 USD and put options representing 1,242,500 of underlying shares valued at $37,461,375 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 661,786 567,402 601.16 19,953 509.04 0.1165
2026-02-17 2025-12-31 13F IMMUNOCORE HLDGS ADS 45258D105 94,384 -369,278 -79.64 3,276 -80.55 0.0225
2025-11-14 2025-09-30 13F IMMUNOCORE HLDGS ADS 45258D105 463,662 284,159 158.30 16,845 199.08 0.1314
2025-08-14 2025-06-30 13F IMMUNOCORE HLDGS ADS 45258D105 179,503 150,110 510.70 5,633 545.87 0.0623
2025-05-15 2025-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 29,393 29,393 872 0.0084
2024-08-14 2024-06-30 13F IMMUNOCORE HLDGS ADS 45258D105 0 -9,212 -100.00 0 -100.00
2024-05-15 2024-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 9,212 9,212 599 0.0091
2023-05-15 2023-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 0 -12,000 -100.00 0 -100.00
2023-02-14 2022-12-31 13F IMMUNOCORE HLDGS ADS 45258D105 12,000 12,000 685 0.0107
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNOCORE HLDGS ADS Call 30,000 904 n/a n/a n/a
2026-02-17 2025-12-31 13F IMMUNOCORE HLDGS ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNOCORE HLDGS ADS Call 64,400 2,340 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNOCORE HLDGS ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNOCORE HLDGS ADS Call 27,500 816 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNOCORE HLDGS ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNOCORE HLDGS ADS Call 12,500 389 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNOCORE HLDGS ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNOCORE HLDGS ADS Call 162,000 10,530 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNOCORE HLDGS ADS Put 1,242,500 4,870.00 37,461 4,220.76 n/a n/a n/a
2026-02-17 2025-12-31 13F IMMUNOCORE HLDGS ADS Put 25,000 -98.39 868 -98.46 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNOCORE HLDGS ADS Put 1,552,500 125.92 56,402 161.56 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNOCORE HLDGS ADS Put 687,200 2,398.91 21,564 2,545.89 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNOCORE HLDGS ADS Put 27,500 816 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNOCORE HLDGS ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNOCORE HLDGS ADS Put 12,500 389 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNOCORE HLDGS ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNOCORE HLDGS ADS Put 37,600 2,444 n/a n/a n/a
2023-05-15 2023-03-31 13F IMMUNOCORE HLDGS ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F IMMUNOCORE HLDGS ADS Put 27,500 1,569 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.